Patricia Kovacevic, General Counsel and Chief Compliance Officer (Nicopure Labs), has communicated throughout the rulemaking process to inform the public of what to expect when the FDA releases its deeming regulation.
The expert gives an overview of the FDA’s deeming rule effective on August 8, 2016.
